Given that DACH1 and RB1 deletion may co-occur in prostate cancer (Fig. 1B), we sought to determine the functional significance of DACH1 gene deletion, independently of RB1, in the onset and progression of PCa, using a murine model. The gene discussed is RB1; the disease is prostate carcinoma.